TNK2
Summary: This gene encodes a tyrosine kinase that binds Cdc42Hs in its GTP-bound form and inhibits both the intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activity of Cdc42Hs. This binding is mediated by a unique sequence of 47 amino acids C-terminal to an SH3 domain. The protein may be involved in a regulatory mechanism that sustains the GTP-bound active form of Cdc42Hs and which is directly linked to a tyrosine phosphorylation signal transduction pathway. Several alternatively spliced transcript variants have been identified from this gene, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| tyrosine kinase non receptor 2 | MIM:606994 | Ensembl:ENSG00000061938 | HGNC:HGNC:19297 | PA134909759 | 3q29 |
GO terms in TNK2
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IEA | GO:0006897 | endocytosis |
| BP | TAS | GO:0007166 | cell surface receptor signaling pathway |
| BP | IBA | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway |
| BP | TAS | GO:0007264 | small GTPase mediated signal transduction |
| BP | IDA | GO:0016310 | phosphorylation |
| BP | IBA | GO:0030154 | cell differentiation |
| BP | IEA | GO:0034260 | negative regulation of GTPase activity |
| BP | IBA | GO:0038083 | peptidyl-tyrosine autophosphorylation |
| BP | IBA | GO:0042127 | regulation of cell proliferation |
| BP | IBA | GO:0045087 | innate immune response |
| BP | IDA | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation |
| BP | IDA | GO:2000369 | regulation of clathrin-dependent endocytosis |
| CC | IDA | GO:0005634 | nucleus |
| CC | IDA | GO:0005737 | cytoplasm |
| CC | ISS | GO:0005768 | endosome |
| CC | IDA | GO:0005886 | plasma membrane |
| CC | IDA | GO:0005905 | clathrin-coated pit |
| CC | IEA | GO:0005912 | adherens junction |
| CC | HDA | GO:0016020 | membrane |
| CC | IDA | GO:0030136 | clathrin-coated vesicle |
| CC | IEA | GO:0030659 | cytoplasmic vesicle membrane |
| CC | IBA | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane |
| CC | IEA | GO:0048471 | perinuclear region of cytoplasm |
| CC | IDA | GO:0070436 | Grb2-EGFR complex |
| MF | IEA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IDA | GO:0004712 | protein serine/threonine/tyrosine kinase activity |
| MF | IDA | GO:0004713 | protein tyrosine kinase activity |
| MF | IBA | GO:0004715 | non-membrane spanning protein tyrosine kinase activity |
| MF | TAS | GO:0005095 | GTPase inhibitor activity |
| MF | IBA | GO:0005102 | signaling receptor binding |
| MF | IDA | GO:0005154 | epidermal growth factor receptor binding |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
| MF | IPI | GO:0031625 | ubiquitin protein ligase binding |
| MF | IPI | GO:0042802 | identical protein binding |
| MF | IEA | GO:0046872 | metal ion binding |
| MF | ISS | GO:0050699 | WW domain binding |
Gene expression in normal tissue: TNK2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TNK2
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| wikipathways | WP306 | Focal Adhesion |
| wikipathways | WP3941 | Oxidative Damage |
| wikipathways | WP437 | EGF-EGFR Signaling Pathway |
| wikipathways | WP524 | G13 Signaling Pathway |
| pid | cdc42_pathway | CDC42 signaling events |
| netpath | Pathway_EGFR1 | EGFR1 |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD405 | PIK-75 | 2 |
| iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
| iGMDRD512 | nutlin 3 | 2 |
| iGMDRD123 | Isoevodiamine | 2 |
| iGMDRD237 | ABT-751 | 5 |
| iGMDRD314 | Tanespimycin | 2 |
| iGMDRD57 | Chloropentafluorobenzene | 3 |
| iGMDRD351 | GW843682X | 4 |
| iGMDRD415 | LE-135 | 2 |
| iGMDRD289 | Parthenolide | 2 |
| iGMDRD6 | AM-580 | 1 |
| iGMDRD105 | Triptolide | 2 |
| iGMDRD5 | Tyrphostin AG 1478 | 2 |
| iGMDRD137 | Indisulam | 12 |
| iGMDRD202 | Curcumin | 4 |
| iGMDRD103 | SN-38 | 5 |
| iGMDRD82 | Quiflapon | 1 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD505 | Pevonedistat | 3 |
| iGMDRD483 | SCH-529074 | 1 |
| iGMDRD494 | Neopeltolide | 2 |
| iGMDRD1008 | SR-II-138A | 3 |
| iGMDRD772 | BRD4770 | 2 |
| iGMDRD425 | ERASTIN | 2 |
| iGMDRD634 | SCHEMBL2608041 | 2 |
| iGMDRD375 | GW-405833 | 1 |
| iGMDRD679 | Bistramide A | 2 |
| iGMDRD394 | BX-795 | 1 |
| iGMDRD280 | CYTOCHALASIN B | 1 |
| iGMDRD466 | Chaetocin | 3 |
| iGMDRD2 | PK-11195 | 2 |
| iGMDRD152 | 179324-69-7 | 2 |
| iGMDRD193 | Fqi1 | 4 |
| iGMDRD316 | N9-Isopropyl-olomoucine | 1 |
| iGMDRD446 | LY 2183240 | 1 |
| iGMDRD294 | Batimastat | 2 |
| iGMDRD870 | BRD63610 | 2 |
| iGMDRD171 | Pemetrexed | 6 |
| iGMDRD802 | 4-methylfasudil | 2 |
| iGMDRD474 | Avrainvillamide | 2 |
| iGMDRD513 | BML-259 | 2 |
| iGMDRD524 | ISX-9 | 5 |
| iGMDRD356 | PNU-74654 | 2 |
| iGMDRD60 | Quinoclamine | 3 |
| iGMDRD64 | Parbendazole | 4 |
| iGMDRD562 | Navitoclax | 2 |
| iGMDRD887 | Compound 23 citrate | 2 |
| iGMDRD399 | Selumetinib | 3 |
| iGMDRD74 | Idarubicin | 5 |
| iGMDRD188 | Piperlongumine | 5 |
| iGMDRD100 | Zebularine | 4 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in TNK2

